You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free M1902_SIGMA ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free M4125_SIAL ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free M8429_SIAL ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free M9546_SIAL ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Mannitol 5% W/Dextrose 5% in Sodium Chloride 0.12%

Last updated: August 12, 2025

Introduction

The pharmaceutical industry relies heavily on the sourcing of high-quality Active Pharmaceutical Ingredients (APIs) essential for compounded medications and commercial formulations. For complex formulations like Mannitol 5% with Dextrose 5% in Sodium Chloride 0.12%, identifying reliable, compliant, and cost-effective API suppliers is crucial. This article provides an in-depth analysis of reputable sources for bulk APIs, focusing on manufacturing standards, market offerings, and procurement strategies tailored for this specific composition.

Composition and Significance of the Formulation

The parenteral preparation combining Mannitol, Dextrose, and Sodium Chloride is commonly used as a vehicle in infusion therapy and as a solvent in pharmaceutical compounding. The APIs involved are:

  • Mannitol: A sugar alcohol used as an osmotic diuretic and a volume expander.
  • Dextrose (D-glucose): A carbohydrate providing calories and used as an energy source.
  • Sodium Chloride: A crystallized salt maintaining osmotic balance.

Manufacturing these components in a sterile, pyrogen-free environment with consistent API quality is critical for patient safety and efficacy.

Global API Manufacturing and Sourcing Landscape

1. Pharmaceutical-Grade API Manufacturers

The APIs for Mannitol, Dextrose, and Sodium Chloride are produced by established pharmaceutical ingredient manufacturers adhering to cGMP (current Good Manufacturing Practices).

Mannitol API Suppliers

  • Roquette Freres (France): A leading global manufacturer with a robust portfolio of pharmaceutical, food, and industrial-grade Mannitol. Their USP/BP compliant Mannitol is widely used in injectable and oral formulations.
    Strengths: Consistent quality, extensive regulatory documentation, global supply chain.
  • Fuso Chemical (Japan): Supplies pharmaceutical-grade Mannitol with high purity standards, including sterile and non-sterile forms.
    Strengths: High-quality manufacturing, proven regulatory track record.
  • Merck KGaA (Germany): Produces Mannitol for pharmaceutical purposes with extensive regulatory approvals.

Dextrose API Suppliers

  • Cargill (USA): Offers pharmaceutical-grade Dextrose Monohydrate compliant with USP and EP standards.
    Strengths: Reliable supply, regulatory compliance, extensive distribution channels.
  • Archer Daniels Midland (ADM, USA): Supplies high-quality Dextrose suitable for injectable and sterile formulations.
    Strengths: Proven quality, global scale.
  • Roquette (France): Also a key supplier, offering pharmaceutical-grade Dextrose in sterile forms.

Sodium Chloride API Suppliers

  • Tata Chemicals (India): Provides pharmaceutical-grade Sodium Chloride with certifications suitable for parenteral use.
  • British Salt (UK): Supplies USP/BP-compliant Sodium Chloride, marketed for sterile and injectable applications.
  • SASOL (South Africa): Offers high-purity Sodium Chloride for pharmaceutical use.

2. Contract Manufacturing and Custom API Sourcing

Many pharmaceutical companies engage Contract Manufacturing Organizations (CMOs) or Active Pharmaceutical Ingredient (API) brokers to source or produce custom APIs, ensuring compliance with local regulatory standards (FDA, EMA, CDSCO). These organizations often facilitate certifications such as DMF (Drug Master File) or CEP (Certificate of Suitability), streamlining approval processes.

3. Regional Considerations

  • Asia-Pacific: Countries such as India and China host numerous API manufacturers offering cost-effective options compliant with international standards. Notable examples include Meerut-based API producers and Chinese GMP-certified plants.
  • Europe: Offers high-purity APIs with rigorous regulatory oversight, necessary for stringent pharmacopoeial requirements.
  • North America: Focuses on supply security and adherence to strict regulatory standards, suitable for global exports.

Key Factors in Choosing API Suppliers

  • Regulatory Approvals: USP, EP, BP, or JP compliance, with validated manufacturing processes.
  • Sterility and Pyrogen-Free Certification: Critical for injectable formulations, demanding endotoxin testing and sterile certifications.
  • Quality Certifications: ISO 9001, cGMP compliance, and supply chain integrity.
  • Supply Chain Reliability: Capacity to meet demand fluctuations and expedite delivery schedules.
  • Cost and Lead Times: Balancing quality with budget constraints and procurement timelines.

Procurement Strategies

  • Established Supplier Relationships: Favor suppliers with proven regulatory track records and rigorous quality control.
  • Technology Due Diligence: Verify API batch testing certificates, stability data, and sterility assurance.
  • Supplier Audits: Conduct on-site assessments or third-party audits to ensure compliance and quality systems.
  • Regulatory Documentation: Ensure availability of DMF, CEP, and comprehensive Certificates of Analysis (CoA).
  • Flexible Sourcing: Establish multiple supplier agreements to mitigate risks and ensure continuous supply.

Regulatory and Quality Considerations

APIs intended for sterile multi-component infusions must meet stringent requirements, including endotoxin limits, sterility, and particulate matter controls. Regulatory agencies such as the FDA and EMA emphasize validated manufacturing processes, comprehensive stability data, and thorough documentation. Importers and formulators must verify API compliance through detailed certificates, stability profiles, and batch testing reports.

Emerging Trends in API Sourcing

  • Increased Use of No-Problem APIs: Suppliers conforming to QS (Quality System) standards integrate risk mitigation strategies to prevent contamination and variability.
  • Sustainable Sourcing and Green Chemistry: Growing emphasis on environmentally friendly manufacturing practices influences supplier selection.
  • Digital Supply Chain Management: Integration of blockchain and digital quality portals for transparency and traceability.

Conclusion

Sourcing APIs for Mannitol 5% with Dextrose 5% in Sodium Chloride 0.12% requires meticulous evaluation of manufacturers, supplier reliability, and regulatory compliance. Leading global players such as Roquette, Cargill, ADM, Tata Chemicals, and British Salt offer high-quality, GMP-compliant APIs suitable for pharmaceutical and parenteral formulations. Strategic procurement, rigorous quality assurance, and understanding regional manufacturing landscapes underpin a resilient supply chain capable of supporting sterile infusion preparations.

Key Takeaways

  • Prioritize suppliers with established regulatory certifications (USP, EP, BP) and cGMP compliance.
  • Verify sterility, endotoxin levels, and batch-specific Certificates of Analysis before procurement.
  • Maintain diversified supplier relationships to mitigate supply chain risks.
  • Stay informed about regional manufacturing standards and emerging trends in sustainable API production.
  • Engage in thorough due diligence, including audits and documentation reviews, to ensure API quality for injectable formulations.

FAQs

1. What are the top global manufacturers for pharmaceutical-grade Mannitol API?

Roquette Freres, Fuso Chemical, and Merck KGaA are leading global providers of pharmaceutical-grade Mannitol, meeting stringent regulatory standards and offering reliable supply chains.

2. How do I verify the quality of APIs for sterile infusion components?

Ensure APIs are supplied with Certificates of Analysis (CoA), endotoxin testing reports, sterility certificates, and compliance documentation like DMFs or CEPs, verified through audits or supplier audits.

3. Can APIs from emerging markets meet international regulatory standards?

Yes. Many Indian and Chinese API manufacturers comply with cGMP and produce USP/EP/BP standards, but thorough qualification and documentation reviews are essential.

4. What are the key considerations when sourcing Sodium Chloride API?

Purity level, compliance with pharmacopeial standards (USP/BP), endotoxin levels, sterility, and certifications are vital for safe, injectable Sodium Chloride.

5. How does regional sourcing affect API quality and cost?

While Asian suppliers may offer cost advantages, European and North American suppliers typically have more extensive regulatory oversight. Balancing cost with compliance and supply security is critical.


Sources:

[1] U.S. Pharmacopeia. (2022). USP Monograph for Mannitol.
[2] European Pharmacopoeia. (2022). EP Monograph for Dextrose and Sodium Chloride.
[3] Roquette Corporate Website. (2023). Pharmaceutical Mannitol Portfolio.
[4] Cargill. (2023). Pharmaceutical Dextrose Monohydrate Details.
[5] Tata Chemicals. (2023). Pharmaceutical Grade Sodium Chloride Product Specs.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.